The current price of ADUS is $124.62 — it has decreased by 1.73% since the previous close. Data as of Nov 6, 2026.
ADUS is down 0.84% over the past week, up 10.10% over the past month and up 9.11% over the past year. The price is above its 200-day moving average of $106.71.
Analysts' average 12-month price target for ADUS is $128.75, which implies 3.31% upside from the current price. Individual estimates range from $96.00 to $148.00.
Of the 14 analysts covering Addus HomeCare Corporation, 3 rate it a strong buy, 8 rate it a buy, 2 rate it a hold and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Addus HomeCare Corporation has a market capitalization of $2.33B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Addus HomeCare Corporation has not paid any dividends over the past year.
Companies most comparable to Addus HomeCare Corporation include Encompass Health Corporation, The Ensign Group, Inc., Chemed Corporation, National HealthCare Corporation and Aveanna Healthcare Holdings Inc.
In the latest trading session ADUS moved between $123.76 and $125.47, a range of 1.37% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Addus HomeCare Corporation shows a buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ADUS has traded between $87.95 and $131.59. The current price is 5.30% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.